[HTML][HTML] Targeted silencing of inhibitors of apoptosis proteins with siRNAs: a potential anti-cancer strategy for hepatocellular carcinoma

G Li, H Chang, YP Zhai, W Xu - Asian Pacific Journal of Cancer …, 2013 - koreascience.kr
Hepatocellular carcinoma (HCC) is one of the most common malignancies, with a very poor
prognosis. Despite significant improvements in diagnosis and treatment in recent years, the …

Targeting apoptosis in autoimmune hepatitis

AJ Czaja - Digestive diseases and sciences, 2014 - Springer
Apoptosis is the predominant mechanism of liver cell death in autoimmune hepatitis, and
interventions that can modulate this activity are emerging. The aim of this review was to …

HtrA1 resensitizes multidrug-resistant hepatocellular carcinoma cells by targeting XIAP

W Bao, F Zhu, Y Duan, Y Yang, H Cai - Biomedicine & Pharmacotherapy, 2015 - Elsevier
The study aims to clarify the relation between chemosensitivity and HtrA1 expression, and
the possible way HtrA1 works. Drug-resistant cell line HepG2/ADM was induced by …

Vitamin C enhances anticancer activity in methotrexate‑treated Hep3B hepatocellular carcinoma cells

GT Yiang, PL Chou, YT Hung, JN Chen… - Oncology …, 2014 - spandidos-publications.com
Methotrexate (MTX) has been widely used for rheumatoid arthritis therapy for a long time.
MTX is also used as an anticancer drug for various tumors. However, many studies have …

The SMAC mimetic APG-1387 sensitizes immune-mediated cell apoptosis in hepatocellular carcinoma

Z Chen, J Chen, H Liu, W Dong, X Huang… - Frontiers in …, 2018 - frontiersin.org
The inhibitor of apoptosis protein (IAP) genes are frequently overexpressed in malignancies.
Second mitochondria-derived activator of caspase (SMAC) mimetics, which target IAPs …

A small molecule inhibitor of XIAP induces apoptosis and synergises with vinorelbine and cisplatin in NSCLC

EJ Dean, T Ward, C Pinilla, R Houghten… - British journal of …, 2010 - nature.com
Background: Evasion of apoptosis contributes to the pathogenesis of solid tumours including
non-small cell lung cancer (NSCLC). Malignant cells resist apoptosis through over …

X-linked inhibitor of apoptosis protein as a therapeutic target

EJ Dean, M Ranson, F Blackhall… - Expert opinion on …, 2007 - Taylor & Francis
Dysregulation of apoptosis has been shown to contribute to many diseases, including
cancer formation, development and resistance, as well as neurodegenerative and …

Bmi1 gene silencing inhibits the proliferation and invasiveness of human hepatocellular carcinoma cells and increases their sensitivity to 5-fluorouracil

R Zhang, LB Xu, XJ Yue, XH Yu… - Oncology …, 2013 - spandidos-publications.com
The Bmi1 gene has been reported to play important roles in cancer initiation and
progression. The aim of this study was to investigate the effects of RNA interference (RNAi) …

Enhanced sensitivity of hepatocellular carcinoma cells to chemotherapy with a Smac-armed oncolytic adenovirus

Q Pan, S Zhong, B Liu, J Liu, R Cai, Y Wang… - Acta Pharmacologica …, 2007 - nature.com
Aim: The aim of the present study was to further improve the therapeutic effects for human
hepatocellular carcinoma (HCC) and reduce the damage in normal cells using a novel …

Adenovirus-mediated down-regulation of X-linked inhibitor of apoptosis protein inhibits colon cancer

Y Dai, L Qiao, KW Chan, M Yang, J Ye, R Zhang… - Molecular cancer …, 2009 - AACR
Our previous studies and those of others have indicated that X-linked inhibitor of apoptosis
protein (XIAP) holds promise as a target gene in colon cancer gene therapy. In this study, we …